Sep
22
2025
Bristol Myers Squibb aligns UK and US prices for new schizophrenia drug
US pharmaceutical company Bristol Myers Squibb will sell its new schizophrenia treatment in the UK for $22,500 a year, the same price as its American version, at a time when...
